The current stock price of IONM is 2.43 USD. In the past month the price decreased by -43.04%. In the past year, price decreased by -82%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.33 | 98.53B | ||
| CI | THE CIGNA GROUP | 9.65 | 73.22B | ||
| LH | LABCORP HOLDINGS INC | 16.81 | 22.05B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 117.04 | 21.53B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.7 | 20.31B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.38B | ||
| DVA | DAVITA INC | 12.91 | 8.41B | ||
| HIMS | HIMS & HERS HEALTH INC | 67.24 | 8.27B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 34.45 | 6.34B | ||
| CHE | CHEMED CORP | 19.52 | 6.08B | ||
| RDNT | RADNET INC | 207.37 | 6.08B | ||
| OPCH | OPTION CARE HEALTH INC | 20.58 | 4.87B |
Assure Holdings Corp is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Greenwood Village, Colorado and currently employs 95 full-time employees. The company went IPO on 2017-07-17. Assure Holdings Corp. is a provider of outsourced intraoperative neurophysiological monitoring (IONM) and remote neurology services. The firm delivers a suite of clinical and operational services to support surgeons and medical facilities during invasive procedures. Its IONM tool is used for various surgical verticals, such as neurosurgery, spine, ear, nose, and throat, and other surgical procedures. Its in-house interoperative neurophysiologists (INP) provide the technical component IONM services from the operating room throughout the procedure, while telehealth-oriented supervising practitioners provide a level of redundancy and risk mitigation in support of the onsite INPs and the surgical team. The company offers IONM services, including scheduling the INP and supervising practitioner, real-time monitoring, patient advocacy and subsequent billing for services provided. During each procedure, it provides two types of services, the Technical Component and Professional Component of IONM.
ASSURE HOLDINGS CORP
7887 East Belleview Avenue, Suite 500
Greenwood Village COLORADO US
CEO: John Farlinger
Employees: 95
Phone: 17202873093
Assure Holdings Corp is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Greenwood Village, Colorado and currently employs 95 full-time employees. The company went IPO on 2017-07-17. Assure Holdings Corp. is a provider of outsourced intraoperative neurophysiological monitoring (IONM) and remote neurology services. The firm delivers a suite of clinical and operational services to support surgeons and medical facilities during invasive procedures. Its IONM tool is used for various surgical verticals, such as neurosurgery, spine, ear, nose, and throat, and other surgical procedures. Its in-house interoperative neurophysiologists (INP) provide the technical component IONM services from the operating room throughout the procedure, while telehealth-oriented supervising practitioners provide a level of redundancy and risk mitigation in support of the onsite INPs and the surgical team. The company offers IONM services, including scheduling the INP and supervising practitioner, real-time monitoring, patient advocacy and subsequent billing for services provided. During each procedure, it provides two types of services, the Technical Component and Professional Component of IONM.
The current stock price of IONM is 2.43 USD. The price decreased by -11.64% in the last trading session.
IONM does not pay a dividend.
IONM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
7 analysts have analysed IONM and the average price target is 4.08 USD. This implies a price increase of 67.9% is expected in the next year compared to the current price of 2.43.
ASSURE HOLDINGS CORP (IONM) will report earnings on 2024-08-12, after the market close.
You can find the ownership structure of ASSURE HOLDINGS CORP (IONM) on the Ownership tab.
ChartMill assigns a fundamental rating of 2 / 10 to IONM. IONM has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months IONM reported a non-GAAP Earnings per Share(EPS) of -41.62. The EPS decreased by -6836.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -251.76% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
7 analysts have analysed IONM and the average price target is 4.08 USD. This implies a price increase of 67.9% is expected in the next year compared to the current price of 2.43.
For the next year, analysts expect an EPS growth of 95.91% and a revenue growth 13.65% for IONM